Promotion of Regular Oesophageal motility to Prevent regurgitation and Enhance nutrition intake in Long-stay ICU patients. A multicenter, Phase II, sham-controlled, randomized trial: The PROPEL Study

The PROPEL study represents an exciting collaboration between CERU and E-Motion Medical Ltd. to to assess the efficacy and safety of the E-Motion Systemâ„¢ on the promotion of GI motility in critically ill patients. 

This trial is registered at ClinicalTrials.gov (NCT02515123).

Recruitment: Study participants will be recruited in 8-10 sites across Canada.

Start Date: Winter 2016

For more information please contact the CERU This email address is being protected from spambots. You need JavaScript enabled to view it. Jennifer Korol.